PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
31-Aug-2023 HAEMATO AG publishes figures for the first half of 2023 HAEMATO AG
30-Aug-2023 IGEA Pharma N.V.: IGEA filed the appeal on SIX decision of delisting IGEA Pharma N.V.
30-Aug-2023 Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics Relief Therapeutics Holding SA
30-Aug-2023 Kinarus Therapeutics Group Reports First Half 2023 Financial Results Kinarus Therapeutics Holding AG
30-Aug-2023 BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions BRAIN Biotech AG
30-Aug-2023 PAION AG reports financial results for the First Half-Year 2023 PAION AG
30-Aug-2023 Formycon reports successful first half of 2023 Formycon AG
30-Aug-2023 MODERN DENTAL GROUP DOUBLED ITS NET PROFIT TO HK$210M FOR THE FIRST HALF OF 2023 DRIVEN BY ACCELERATED DIGITALISATION IN DENTISTRY Modern Dental Group Limited
29-Aug-2023 Purification solutions in large-scale manufacturing of oligonucleotide APIs Bachem
29-Aug-2023 Vetter Earns Frost & Sullivan’s Customer Value Award for the Third Time B3C newswire
29-Aug-2023 Malaysian Genomics Unveils Strategic Advances in Biopharmaceuticals Malaysian Genomics Resource Centre Bhd
29-Aug-2023 Serca Pharmaceuticals presents first-in-class strategy for game-changing, post heart-attack cardioprotection at European Society of Cardiology Congress 2023 Serca Pharmaceuticals
29-Aug-2023 Danaher to acquire Abcam for $24.00 per Share Abcam plc
29-Aug-2023 Pharmaceutical companies maintain reputation post-pandemic, new research finds ABPI
29-Aug-2023 Mainz Biomed to Present at the H.C. Wainwright Global Investment Conference Mainz BioMed N.V.
29-Aug-2023 Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall Dermapharm Holding SE
29-Aug-2023 Formycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 (aflibercept), by the U.S. Food and Drug Administration (FDA) Formycon AG
29-Aug-2023 Evotec SE reports results for the first half-year 2023 and provides corporate updates Evotec SE
28-Aug-2023 Uni-Bio Science Group Limited Announces 2023 Interim Results UNI-BIO SCIENCE GROUP LIMITED
28-Aug-2023 T-CURX GmbH Announces Appointment of Two Industry Leaders to its Board of Directors B3C newswire